WIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The International trademark AMGEN was filed as Word mark on 02/09/2006 at the World Intellectual Property Organization.
| Trademark form | Word mark |
| File reference | 893256 |
| Countries | 
|
| Base trademark |
No. ,
October 1, 2024
|
| Application date | February 9, 2006 |
| Expiration date | February 9, 2026 |
Trademark owner
One Amgen Center Drive
Thousand Oaks, CA 91320-1799
US
Thousand Oaks, CA 91320-1799
US
Trademark representatives
444 West Lake Street, Suite 4000
Chicago Illinois 60606-0029
US
goods and services
05
Pharmaceutical preparations, namely, erythropoietin for use
in treating chronic anemia, granulocyte colony stimulation
factor, granulocyte-macrophage colony stimulating factor for
use in restoring the level of white blood cells, hepatitis B
vaccine, interferon and interleukin 2 for use in anticancer
and antiviral applications, epidermal growth factor and
platelet-derived growth factor for use in treating surgical
or soft tissue damage; a full line of pharmaceuticals, and
pharmaceuticals, including human recombinant erythropoietin
and erythropoiesis stimulating protein; pharmaceuticals for
use in stimulating production of red blood cells, white
blood cells or platelets; pharmaceuticals for modulating
calcium, phosphorus, or parathyroid hormone levels in the
blood or for treatment of hyperparathyroidism, hypercalcemia
or bone metabolism related disorders and diseases;
pharmaceuticals for treating human immune diseases and
conditions; pharmaceuticals for the treatment of viral
infections, neoplastic, metabolic, autoimmune or
inflammatory disorders; pharmaceuticals for the treatment of
injury to epithelial cells and tissues; pharmaceuticals for
modulating weight loss, regulating reproductive function and
promoting wound healing, and for use in the treatment of
obesity, diabetes, hypertension, dyslipidemia and
cardiovascular diseases and infertility; support kits for
patients afflicted with autoimmune or inflammatory
disorders, comprised primarily of materials for wound
dressing and sterilization; one or more of the
aforementioned pharmaceutical preparations sold in prefilled
syringes
10
Medical apparatus, namely a reusable device which assists in
removing needle guards and adds stability to delivery of
drugs by syringe and a reusable spring-loaded medical
syringe holder for facilitating delivery of drugs by
syringe; injectors for medical purposes; device for delivery
of a drug
42
Genetic engineering research and development services for
others; medical research namely, clinical trial services
44
Information services, namely providing information of
interest to cancer patients; information services relating
to medical services via a global computer network
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| February 9, 2016 | 2016/7 Gaz | Extension | |
| June 24, 2011 | 2012/4 Gaz | US | RAW: Partial Ceasing Effect |
| June 18, 2008 | 2008/28 Gaz | TR | RAW: Protection Granted |
| September 25, 2007 | 2007/41 Gaz | GE | RAW: Protection Granted |
| February 9, 2006 | 2006/35 Gaz | US | Registration |
| Partial deletion |
ID: 14893256